BDF
CAPR icon

Black Diamond Financial’s Capricor Therapeutics CAPR Stock Holding History

Black Diamond Financial’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Hold
79,077
– – 0.17% 61
2026
Q1 		$2.4M Hold
79,077
– – 0.26% 51
2025
Q4 		$2.28M Sell
79,077
-198,660
-72% -$2.59M 0.24% 56
2025
Q3 		$2M Hold
277,737
– – 0.22% 57
2025
Q2 		$2.76M Hold
277,737
– – 0.43% 42
2025
Q1 		$2.64M Hold
277,737
– – 0.4% 42
2024
Q4 		$3.83M Buy
+277,737
New +$4.87M 0.57% 42

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Black Diamond Financial's CAPR Position: Q2 2026 in Review

Black Diamond Financial held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 79,077 shares worth $1.9M. The position accounts for 0.17% of the portfolio, ranked #61.

Black Diamond Financial first reported a position in CAPR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.83M in Q4 2024. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Black Diamond Financial held 79,077 shares of Capricor Therapeutics worth $1.9M as of Q2 2026.
  • Black Diamond Financial left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up 0.17% of Black Diamond Financial's portfolio in Q2 2026, its #61 holding.
  • Black Diamond Financial first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Black Diamond Financial's Capricor Therapeutics position peaked at $3.83M in Q4 2024.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Black Diamond Financial's 13F filing for Q2 2026, filed 4 Aug 2026.